APA (7th ed.) Citation

U, O., O, K., D, I., YE, A., S, A. E., H, S., . . . N, T. (2026). Association Between Time to PSA Nadir, Radiologic Progression, and PSA Progression in mHSPC Patients Treated with Abiraterone or Enzalutamide. Journal of clinical medicine, 15(1), . https://doi.org/10.3390/jcm15010386

Chicago Style (17th ed.) Citation

U, Ozkerim, Kinikoglu O, Isik D, Altintas YE, Ay Ersoy S, Surmeli H, Odabas H, Basoglu T, and Turan N. "Association Between Time to PSA Nadir, Radiologic Progression, and PSA Progression in MHSPC Patients Treated with Abiraterone or Enzalutamide." Journal of Clinical Medicine 15, no. 1 (2026). https://doi.org/10.3390/jcm15010386.

MLA (9th ed.) Citation

U, Ozkerim, et al. "Association Between Time to PSA Nadir, Radiologic Progression, and PSA Progression in MHSPC Patients Treated with Abiraterone or Enzalutamide." Journal of Clinical Medicine, vol. 15, no. 1, 2026, https://doi.org/10.3390/jcm15010386.